Class IIIOngoingD-0896-2023
Drug recall · July 19, 2023
PANCREAZE recall
Why: Failed Stability Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Campbell, CA 95008, UPC: N3 62541-401-10 5, NDC 62541-401-10,
- Lots / codes
Lot #: 102101, Exp: 31 July 2024
- Quantity
- 4240 bottles
- Company
- Vivus, Inc., Campbell, CA
- Distribution
- Nationwide within the United States
- Initiated
- June 23, 2023 · Voluntary: Firm initiated
- Classified
- July 7, 2023
- Reported
- July 19, 2023
- How notified
- N/A
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.